Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

OPtimization of Antiplatelet Therapy After the intervenTION of de Novo Coronary Artery Lesions With Drug-Coated Balloons

NCT07815106 is registered in ClinicalTrials.gov with Shanghai Zhongshan Hospital as lead sponsor.

NCT NCT07815106
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07815106 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
OPtimization of Antiplatelet Therapy After the intervenTION of de Novo Coronary Artery Lesions With Drug-Coated Balloons
Lead sponsor
Shanghai Zhongshan Hospital
Phase
Phase 4
Overall status
Not yet recruiting
Start date
October 1, 2026
Completion date
September 30, 2029
Enrollment
2,122 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

chronic coronary syndrome